Replies to post #18555 on DNAprint Genomics (DNAG)

[gunnabeoneday]

Frog, point being, that even with a 40% discount versus the Jan pps, he's better off having the money at this point in time.

Agree?


And what was the amount he was paid, $40,000 or so? I just don't see this issue having any impact on dnap's pps as some here [the good DrCal] are saying. Isn't he suing to get paid in shares versus the money he was already paid? What's Dnap's exposure here?

Thanks for your input.

[DRCAL]

This sounds like a reason explanation at first, but why should any company go through with this bizzare way of financing? Options could easily have been issued, especially for the business angel and star scientific officer.
Your explanation doesn't ring right. There is more to the issue such as percentage of stock owned.